1 / 24

Laboratory Integration in Influenza Surveillance

Laboratory Integration in Influenza Surveillance. Dr Geethani Wickramasinghe NIC- Sri Lanka. Introduction. Sri Lanka is a developing country with limited resources There was no organized continuous influenza surveillance until recent past (2007) Initially, only outbreak surveillance

rehan
Télécharger la présentation

Laboratory Integration in Influenza Surveillance

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Laboratory Integration in Influenza Surveillance Dr Geethani Wickramasinghe NIC- Sri Lanka

  2. Introduction Sri Lanka is a developing country with limited resources There was no organized continuous influenza surveillance until recent past (2007) Initially, only outbreak surveillance 1998 - Inf A H3N2 Sydney 5/97 Influenza surveillance was initiated under AI preparedness plan of GISN Focal point- Epidemiology unit of MoH

  3. National influenza network • ILI surveillance • 2005 - started from Western province in Childrens hospital (LRH), Colombo • 2007 - Extended to sentinel sites, 20 sites to include all the provinces • SARI surveillance • 3 sites (LRH, GH/Matara, TH Peradeniya) -2010 • Network of labs -1 NIC & 2 provincial (Southern & Central)

  4. Training programmes were conducted by the Epi – Lab team in these sites. ICN were trained in collection of samples & proper transport. Introduced case definitions • At the start VTM & swabs were prepared by the NIC & distributed to these sites. Now commercial swabs & media are used

  5. Each site – 30 specimens / month to NIC • Laboratory methods • Initially - DFT & Virus isolation • Rapid tests were not used • Later molecular techniques • Conventional PCR initially • rt Rt PCR introduced in 2009 • 2010 - Changed testing protocols • All specimens - PCR • Positives – virus isolation • SARI samples - PCR & DFT for all respiratory viruses

  6. Participated in WHO EQA programmes since 2007 – 9 panels -now 100% performance • Laboratory Accreditation by CDC in 2010 • Funds • WHO, WB, CDC - Equipments, Reagents • Tsunami Funds/pasteur institute - Training programmes

  7. Weekly Data Collection Form for Cases of Influenza- Like Illness (ILI)

  8. Dissemination of information Data reporting – by telephone, fax & emails weekly / monthly print reports To the Epidemiology unit & MoH During the pandemic - daily reports Weekly data to Flunet Monthly technical committee meetings - human/animal surveillance, Epid unit, Health Education Bureau for communication, control activities During the pandemic - guideline preparation & management protocols, control & preventive strategies - by the technical committee

  9. Dissemination of data Hospital performance published monthly in WER and Unit Website & presented at the monthly AI/PI technical committee meeting Also presented quarterly for the Quarterly Review Meeting of Epidemiologists & published in Quarterly Epidemiological Bulletin

  10. Data Compilation and Feed back National level feedback Weekly Epidemiological Report (WER) Quarterly Epidemiological Bulletin www.epid.gov.lk

  11. ILI surveillance in SL - 2005- 2009

  12. ILI Surveillance – Samples Received from sentinel sites - 2010 NIC/MRI

  13. Virus activity in Sri Lanka from 2005 - 2008

  14. Rain fall pattern from 2006 - 2010

  15. PA(H1N1) cases from June 2009–May 2011

  16. Age Distribution of Confirmed cases & deaths in 2009 & 2010 NIC/MRI

  17. Liaison with reference laboratories Sharing of Influenza viruses with ref labs WHO CC – Melbourne, Ausralia & Hong Kong University Inf sub types & un-typed viruses - 2-3/year, World Courier- Global funds Benefits - Confidence - Sub typing of untypable viruses - Anti-viral susceptibility monitoring - Gene sequencing

  18. Problems • Inadequate collection of specimens from some sentinel sites • Difficulty in transport of specimens from distance sites • Poor performance of sub-national laboratories • Initiation of anti-viral susceptibility monitoring & sequencing studies by the NIC

  19. Control activities Health Education School closure Vaccine recommendations 2010 - Introduced mono-valent Pandemic influenza vaccine 2011 – Seasonal vaccine was registered for the first time in SL depending on the Inf surveillance data

  20. Future • Improvement of sub-national laboratories • Improvement of routine surveillance activities • Disease burden studies • Initiation of drug resistance monitoring • Collaborative research with animal surveillance center – VRI • Gene sequencing

  21. Thank you

More Related